Forte Biosciences Announces Proposed Public Offering
Forte Biosciences, Inc. (FBRX)
Company Research
Source: Business Wire
DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Forte expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock. All of the shares of common stock are being offered by Forte. The proposed offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.Forte intends to use the net proceeds of the offering for working capital and other general corporate purposes, which includes funding clinical development of its product candidate and other research activities.Guggenheim Securities is acting as book-running manager for the offering.The offering is being made pursuant to a Registr
Show less
Read more
Impact Snapshot
Event Time:
FBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FBRX alerts
High impacting Forte Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
FBRX
News
- Forte Biosciences Announces Pricing of $150 Million Public OfferingBusiness Wire
- Forte Biosciences, Inc. Announces 2025 Results and Provides UpdateBusiness Wire
- Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing RulesBusiness Wire
- Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing RulesBusiness Wire
- Forte Biosciences, Inc. to Present at Upcoming Investor MeetingsBusiness Wire
FBRX
Sec Filings
- 4/3/26 - Form 4
- 4/3/26 - Form 4
- 2/17/26 - Form SCHEDULE
- FBRX's page on the SEC website